¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 5) : 2022-04-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 5) : 2022-04-03
±³À°ÀÏÀÚ : 2022-04-03
±³À°Àå¼Ò : (¿Â, ¿ÀÇÁ¶óÀÎ º´Çà) ¿ÀÇÁ¶óÀÎ Àå¼Ò: ¼­¿ï ÄÚ¿¢½º  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) APASL 2022 (DAY 5)
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : APASL 2022 Áغñ»ç¹«±¹
¿¬¶ôó : 02-707-0091  
À̸ÞÀÏ : apasl2022@insession.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 800,000¿ø      
ºñ°í Category Early Bird Rate Regular Rate Onsite Rate December 31(Fri), 2021 February 20(Sun), 2022 Off-line Virtual Off-line Virtual Off-line VirtualAPASL Member USD 300 USD200 USD400 USD300 USD 500 USD 400Non APASL Member USD 500 USD 300 USD 600 USD 400 USD 700 USD 500Trainee/Resident/Nurse USD 200 USD 100 USD 300 USD 200 USD 400 USD 300Accompanying Person USD 150 - USD 200 - USD 300 -Industry Partner USD 600 USD 600 USD 700 USD 700 USD 800 USD 800 / *»çÀüµî·Ï2022³â 2¿ù 20ÀÏ(ÀÏ)±îÁö [ÇöÀå] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 15¸¸¿ø, µ¿¹ÝÀÚ 15¸¸¿ø, Industry Partner 70¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 25¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 12¸¸¿ø, Industry Partner 70¸¸¿ø, *ÇöÀåµî·Ï [ÇöÀå] Àü¹®ÀÇ 35¸¸¿ø, ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç 18¸¸¿ø, µ¿¹ÝÀÚ 18¸¸¿ø, Industry Partner 80¸¸¿ø [¿Â¶óÀÎ] Àü¹®ÀÇ 30¸¸¿ø, ÀüÀÓÀÇ/Àü°øÀÇ/°£È£»ç 15¸¸¿ø, Industry Partner 80¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-03 101, 1F 08:30~08:40 Alcohol-induced glutamate vesicles trigger inflammatory liver injury through Kupffer cell activation  Keungmo Yang(Korea advanced institute of science and technology) 
±³À°½Ã°£ 04-03 101, 1F 08:40~08:50 In vivo RNA-interference (RNAi) screen identifies potential regulators of liver regeneration and disease  Viktoriia Iakovleva(Genome Institute of Singapore) 
±³À°½Ã°£ 04-03 101, 1F 08:50~09:00 Risk of hepatocellular carcinoma, but not hepatic decompensation, persists beyond 7 years after hepatitis B surface antigen seroclearance: a territory-wide cohort of 9,769 patients  Terry Cheuk-Fung Yip(Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong) 
±³À°½Ã°£ 04-03 101, 1F 09:00~09:10 Progress towards hepatitis C elimination: The feasibility and success of a nurse and harm reduction practitioner led model of care utilising rapid point of care HCV RNA testing at a medically supervis  Michael Macisaac(St Vincent) 
±³À°½Ã°£ 04-03 101, 1F 09:10~09:20 LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis  Gang Li(NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China;) 
±³À°½Ã°£ 04-03 101, 1F 09:20~09:30 L-ornithine L-aspartate in acute treatment of severe Hepatic encephalopathy: A double-blind randomized controlled trial  Arpan Jain(Department of Gastroenterology, GB Pant Hospital, New Delhi) 
±³À°½Ã°£ 04-03 101, 1F 09:30~09:40 The Accuracy of Microvascular Invasion Prediction Based on Radiomics Methods in Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis of Diagnostic Study  Mochamad Afifudin(Universitas Islam Indonesia) 
±³À°½Ã°£ 04-03 101, 1F 09:40~09:50 Surgical outcomes of pure laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma  Kyeong Deok Kim(Samsung Medical Center) 
±³À°½Ã°£ 04-03 101, 1F 09:50~10:00 Long term post-transplant survival outcome following the bridging locoregional therapy in hepatocellular carcinoma patients: A systematic review and meta-analysis study  Alan Chuncharunee(Division of gastroenterology and hepatology, Department of internal medicine, Faculty of medicine, Ramathibodi hospital, Mahidol University, Bangkok, Thailand) 
È޽Ġ04-03 101, 1F 10:00~10:10 Break  () 
±³À°½Ã°£ 04-03 101, 1F 10:10~10:40 Hepatitis  Jun Yong Park(Yonsei University College of Medicine) 
±³À°½Ã°£ 04-03 101, 1F 10:40~11:10 Cirrhosis and others  Dong Hyun Sinn(Sungkyunkwan University School of Medicine) 
±³À°½Ã°£ 04-03 101, 1F 11:10~11:40 Liver cancer  Ju Hyun Shim(University of Ulsan College of Medicine) 
±³À°½Ã°£ 04-03 102, 1F 08:30~08:40 Japan  Osamu Yokosuka(Graduate School of Medicine, Chiba University) 
±³À°½Ã°£ 04-03 102, 1F 08:40~08:50 Taiwan  Han-Chieh Lin(Taipei Veterans General Hospital) 
±³À°½Ã°£ 04-03 102, 1F 08:50~09:00 Philippines  Diana A Payawal(Fatima University Medical Center) 
±³À°½Ã°£ 04-03 102, 1F 09:00~09:10 Thailand  Tawesak Tanwandee(Siriraj Hospital, Mahidol University) 
±³À°½Ã°£ 04-03 102, 1F 09:10~09:20 Armenia  Hasmik Ghazinyan(Norq Clinical Hospital of Infectious Diseases) 
±³À°½Ã°£ 04-03 102, 1F 09:20~09:30 Turkey  A.Kadir Dokmeci(Ankara University School of Medicine) 
±³À°½Ã°£ 04-03 102, 1F 09:30~09:40 Pakistan  Saeed Sadiq Hamid(Aga Khan University and Hospital) 
±³À°½Ã°£ 04-03 102, 1F 09:40~09:50 Malaysia  Rosmawati Mohamed(Faculty of Medicine, University of Malaya) 
È޽Ġ04-03 101, 1F 09:50~10:10 Break  () 
±³À°½Ã°£ 04-03 102, 1F 10:10~10:20 India  Barjesh C Sharma(G B Pant Hospital) 
±³À°½Ã°£ 04-03 102, 1F 10:20~10:30 China  Jinlin Hou(Nanfang Hospital, Southern Medical University) 
±³À°½Ã°£ 04-03 102, 1F 10:30~10:40 Vietnam  Trung Hai Le(Hanoi General Hospital) 
±³À°½Ã°£ 04-03 102, 1F 10:40~10:50 Indonesia  Rino A Gani(Cipto Mangunkusumo Hospital) 
±³À°½Ã°£ 04-03 102, 1F 10:50~11:00 Kazakhstan  Alexander V. Nersesov(Kazakh National Medical University) 
±³À°½Ã°£ 04-03 102, 1F 11:00~11:10 Australia  Darrell Crawford(The University of Queensland) 
±³À°½Ã°£ 04-03 102, 1F 11:10~11:20 Mongolia  Oidov Baatarkhuu(Mongolian National University of Medical Sciences) 
±³À°½Ã°£ 04-03 102, 1F 11:20~11:30 Korea  Si Hyun Bae(College of Medicine, The Catholic University of Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£ÇÐȸ APASL 2022 (DAY 5) : 2022-04-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹ÀÇÇб³À°ÇÐȸ (¿Â¶óÀÎ) 2022³âµµ ½ÅÀÓ±³¼ö ¿öÅ©¼ó(1ÀÏÂ÷) : 2022-04-07
´ÙÀ½±Û [¿Â¶óÀÎ]Á¦14ȸ Áß¾Ó´ëÇб³º´¿ø ·ù¸¶Æ¼½º ¿¬¼ö°­Á : 2022-04-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 62 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 39 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 46 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 52 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 43 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 39 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 16 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 17 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 35 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 20 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 17 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 41 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 30 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 32 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 24 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷